BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7334812)

  • 1. The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detection.
    Meredith PA; McSharry D; Elliott HL; Reid JL
    J Pharmacol Methods; 1981 Dec; 6(4):309-14. PubMed ID: 7334812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High pressure liquid chromatography on labetalol in serum or plasma.
    Woodman TF; Johnson B
    Ther Drug Monit; 1981; 3(4):371-5. PubMed ID: 7336471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive high-performance liquid chromatographic method for the determination of labetalol in human plasma using fluorimetric detection.
    Oosterhuis B; van den Berg M; van Boxtel CJ
    J Chromatogr; 1981 Nov; 226(1):259-65. PubMed ID: 7320152
    [No Abstract]   [Full Text] [Related]  

  • 4. High-performance liquid chromatographic assay for labetalol in human plasma using a PRP-1 column and fluorometric detection.
    Alton KB; Leitz F; Bariletto S; Jaworsky L; Desrivieres D; Patrick J
    J Chromatogr; 1984 Nov; 311(2):319-28. PubMed ID: 6520179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic method for the determination of labetalol in plasma using ultraviolet detection.
    Hidalgo IJ; Muir KT
    J Chromatogr; 1984 Jan; 305(1):222-7. PubMed ID: 6707148
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.
    McNeil JJ; Anderson AE; Louis WJ; Morgan DJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):157S-161S. PubMed ID: 526397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive high-performance liquid chromatographic method for the determination of labetalol diastereoisomers in plasma samples without derivatization.
    Grellet J; Michel-Gueroult P; Ducint D; Saux MC
    J Chromatogr; 1994 Jan; 652(1):59-66. PubMed ID: 8014228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of fluorescence detection for the determination of labetalol in plasma by high-performance liquid chromatography.
    Ostrovská V; Svobodová X; Pechová A; Kusala S; Svoboda M
    J Chromatogr; 1988 Jul; 446():323-7. PubMed ID: 3209660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of labetalol in human plasma by high-performance liquid chromatography.
    Dusci LJ; Hackett LP
    J Chromatogr; 1979 Jul; 175(1):208-10. PubMed ID: 546907
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined use of an automated sample processor and a polymer-based high-performance liquid chromatographic column to determine the pharmacokinetics of labetalol in man.
    Bates J; Carey PF; Godward RE
    J Chromatogr; 1987 Jun; 395():455-61. PubMed ID: 3624360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive microbore high-performance liquid chromatographic assay for labetalol in the biological fluids of pregnant sheep.
    Yeleswaram K; Axelson JE; Rurak DW
    J Chromatogr; 1991 Apr; 565(1-2):383-90. PubMed ID: 1874882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of bufuralol and its major metabolites in plasma by high-performance liquid chromatography.
    Haefelfinger P
    J Chromatogr; 1980 Dec; 221(2):327-35. PubMed ID: 7217302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The determination of trimazosin and its metabolite CP23445 in whole blood by high performance liquid chromatography using fluorescence detection.
    Hughes MA; Meredith PA; Elliott HL
    J Pharmacol Methods; 1984 Aug; 12(1):29-34. PubMed ID: 6536811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic assay for dilevalol in human plasma and urine using a PRP-1 column and fluorimetric detection.
    Alton KB; Petruzzi RF; Patrick JE
    J Chromatogr; 1988 Mar; 425(2):363-72. PubMed ID: 2897376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved liquid-chromatographic assay of labetalol in plasma.
    Luke DR; Matzke GR; Clarkson JT; Awni WM
    Clin Chem; 1987 Aug; 33(8):1450-2. PubMed ID: 3608164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.
    Daneshmend TK; Roberts CJ
    Br J Clin Pharmacol; 1982 Jul; 14(1):73-8. PubMed ID: 7104169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased first-pass metabolism of labetalol in chronic liver disease.
    Homeida M; Jackson L; Roberts CJ
    Br Med J; 1978 Oct; 2(6144):1048-50. PubMed ID: 709214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated sample preparation on-line with thermospray high-performance liquid chromatography-mass spectrometry for the determination of drugs in plasma.
    Lant MS; Oxford J; Martin LE
    J Chromatogr; 1987 May; 394(1):223-30. PubMed ID: 3597620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labetalol steady-state pharmacokinetics in hypertensive patients.
    McNeil JJ; Anderson AE; Louis WJ; Raymond K
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):75S-80S. PubMed ID: 7093102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive chiral high-performance liquid chromatographic assay for labetalol in biological fluids.
    Dakers JM; Boulton DW; Fawcett JP
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):215-20. PubMed ID: 9518153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.